TKC TURKCELL ILETISIM HIZMETLERI A S IFRS Annual reports only
Telephone Communications (No Radiotelephone) · NYSE · SEC CIK 1071321 · Reporting currency TRY · Fiscal year ends 12/31
Financial factors as of 2023-12-31 (FY2023), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Unit: TRY | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 | FY20192019-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 107.12B | 93.49B | 108.60B | 69.50B | 25.14B |
| Cost of revenue | 84.42B | 81.68B | 86.14B | 53.11B | 17.08B |
| Gross profit | 22.70B | 11.81B | 22.46B | 16.39B | 8.05B |
| R&D expense | 132.63M | 129.08M | 89.90M | 175.11M | — |
| Operating income | 7.81B | 2.95B | 12.10B | 8.99B | 5.03B |
| Interest expense | 19.93B | 11.95B | 21.31B | 8.27B | 2.03B |
| Pretax income | 5.89B | 3.25B | 7.32B | 5.43B | 3.29B |
| Income tax | -4.68B | -2.79B | 900.34M | 919.74M | 785.63M |
| Net income | 12.55B | 6.88B | 7.14B | 4.50B | 3.25B |
| EBITDA | 39.11B | 35.55B | 43.29B | 27.75B | 10.08B |
| EPS (basic) | 5.75 | 3.15 | 3.27 | 2.10 | 1.49 |
| EPS (diluted) | 5.75 | 3.15 | 3.27 | 2.10 | 1.49 |
| Balance sheet | |||||
| Cash & equivalents | 49.98B | 42.78B | 30.60B | 11.86B | 10.24B |
| Receivables | 10.93B | 10.98B | 6.83B | 3.47B | 3.13B |
| Inventory | 540.51M | 494.99M | 458.72M | 203.72M | 178.40M |
| Current assets | 102.55B | 77.31B | 48.57B | 20.58B | 19.33B |
| PP&E, netmay include right-of-use assets (IFRS) | 66.65B | 71.49B | 76.26B | 43.24B | 12.46B |
| Goodwill | — | — | 259.36M | 40.01M | — |
| Total assets | 247.08B | 234.99B | 151.30B | 51.50B | 45.71B |
| Current liabilities | 57.73B | 48.48B | 28.26B | 11.57B | 12.66B |
| Short-term debt | 26.14B | 27.55B | 14.54B | 5.23B | 7.63B |
| Long-term debt | 57.95B | 61.19B | 45.88B | 16.35B | 12.68B |
| Total debt | 84.08B | 88.74B | 60.42B | 21.59B | 20.31B |
| Total liabilities | 124.85B | 125.61B | 85.93B | 30.71B | 27.63B |
| Shareholders' equity | 122.25B | 109.37B | 65.37B | 20.78B | 18.05B |
| Net debt | 34.11B | 45.96B | 29.81B | 9.73B | 10.07B |
| Cash flow statement | |||||
| Operating cash flow | 41.72B | 42.28B | 61.65B | 21.00B | 9.03B |
| Capital expenditure | 14.22B | 15.38B | 18.06B | 8.48B | 3.20B |
| Free cash flow | 27.50B | 26.90B | 43.59B | 12.52B | 5.83B |
| Investing cash flow | -20.91B | -31.71B | -29.01B | -14.54B | -3.03B |
| Financing cash flow | 6.77B | 3.39B | -9.88B | -9.95B | -3.48B |
| Depreciation & amortization | 31.30B | 32.60B | 31.19B | 18.76B | 5.05B |
| Stock-based compensation | 201.14M | 0 | 0 | 12.09M | 28.20M |
| Dividends paid | 2.46B | 2.37B | 8.96B | 1.94B | 1.13B |
| Share buybacks | 50.76M | — | 858,000 | 25.03M | 10.00M |
Free plan shows the latest 5 periods; Pro shows all 9 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· Amounts are in the company's reporting currency, TRY, not USD; the site does no currency conversion.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.